You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RET-PTC3

Showing 1 - 25 of 700
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colo-rectal Cancer Trial in Beijing (adjuvant therapy based on 3D drug sensitivity test results of micro tumor (PTC) in vitro)

Recruiting
  • Colo-rectal Cancer
  • adjuvant therapy based on 3D drug sensitivity test results of micro tumor (PTC) in vitro
  • Beijing, China/Beijing, China
    Peking Union Medical College Hospital, Chinese Academy of Medici
Aug 4, 2023

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

Active, not recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +39 more
  • pralsetinib (BLU-667)
  • Phoenix, Arizona
  • +65 more
Nov 10, 2022

NSCLC, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (LOXO-292)

Recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Scottsdale, Arizona
  • +84 more
Oct 10, 2022

Colon Cancer, Rectal Cancer, Chemo Effect Trial in Beijing (5-fluorouracil + formyltetrahydrofolate/Oxaliplatin + 5-fluorouracil

Recruiting
  • Colon Cancer
  • +4 more
  • 5-fluorouracil + formyltetrahydrofolate/Oxaliplatin + 5-fluorouracil + formyltetrahydrofolate/Irinotecan + 5-fluorouracil + formyltetrahydrofolate/Cetuximab + 5-fluorouracil + formyltetrahydrofolate
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jun 15, 2022

Parkinson's Disease Trial in Germany, United Kingdom, United States (PTC-589)

Completed
Has Results
  • Parkinson's Disease
  • Los Angeles, California
  • +4 more
Apr 6, 2022

Huntington Disease Trial in Worldwide (PTC518, Placebo)

Recruiting
  • Huntington Disease
  • Birmingham, Alabama
  • +18 more
Nov 9, 2022

Sarcopenia, Muscle Atrophy, Osteoporosis Trial in Birmingham (RET, Placebo, Vitamin D3)

Completed
  • Sarcopenia
  • +2 more
  • RET
  • +2 more
  • Birmingham, United Kingdom
    University of Birmingham
Feb 7, 2022

Laparoscopic Colorectal Surgeries Trial in Montréal-Est (Rocuronium IV bolus 0.1 mg/kg guided by TOF that must remain between

Recruiting
  • Laparoscopic Colorectal Surgeries
  • Rocuronium IV bolus 0.1 mg/kg guided by TOF that must remain between 1-3 during surgery
  • Rocuronium IV bolus 0.1 mg/kg guided by TOF 0/4 and PTC≤ 2
  • Montréal-Est, Quebec, Canada
    Hopital Maisonneuve Rosemont, CIUSSS de l'Est de l'Ile de Montré
Apr 4, 2022

Phenylketonuria Trial in Worldwide (PTC923, Placebo)

Recruiting
  • Phenylketonuria
  • Stanford, California
  • +42 more
Nov 23, 2022

NSCLC Trial in Shanghai (SY-5007)

Recruiting
  • Non-Small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Sep 4, 2023

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Chang chun

Not yet recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +3 more
  • Chang chun, Jilin, China
    Jinlin Province Cancer Hosipital
Dec 21, 2022

Phenylketonuria Trial in Worldwide (PTC923)

Recruiting
  • Phenylketonuria
  • Stanford, California
  • +42 more
Jun 23, 2022

MDD Trial in Ames (Resistance Exercise Training)

Active, not recruiting
  • Major Depressive Disorder
  • Resistance Exercise Training
  • Ames, Iowa
    Iowa State University
Jan 12, 2023

Medullary Thyroid Cancer Trial in Worldwide (Selpercatinib, Cabozantinib, Vandetanib)

Recruiting
  • Medullary Thyroid Cancer
  • Birmingham, Alabama
  • +148 more
Jan 18, 2023

Solid Tumor, Medullary Thyroid Cancer Trial in China (Selpercatinib)

Active, not recruiting
Has Results
  • Solid Tumor
  • Medullary Thyroid Cancer
  • Guangzhou, Guangdong, China
  • +12 more
May 9, 2022

Advanced Nonhaematologic Malignancies Trial in Worldwide (BOS172738)

Active, not recruiting
  • Advanced Nonhaematologic Malignancies
  • Philadelphia, Pennsylvania
  • +20 more
Sep 23, 2022

Thyroid Cancer, Thyroid Carcinoma, Metastatic Thyroid Cancer Trial in Boston (Selpercatinib, Sodium Iodine I-131, rhTSH)

Not yet recruiting
  • Thyroid Cancer
  • +5 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Dec 20, 2022

Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Tampa

Recruiting
  • Lung Non-Small Cell Carcinoma
  • +4 more
  • Tampa, Florida
    Moffitt Cancer Center
Aug 16, 2022

Malignant Thyroid Gland Tumor, Poorly Differentiated Thyroid Gland Carcinoma, Recurrent Thyroid Gland Carcinoma Trial in Houston

Recruiting
  • Malignant Thyroid Gland Neoplasm
  • +6 more
  • Quality-of-Life Assessment
  • +3 more
  • Ann Arbor, Michigan
  • +1 more
Jan 24, 2023

Breast Cancer Trial in Netherlands (PTC-Pz)

Active, not recruiting
  • Breast Cancer
  • Alkmaar, Netherlands
  • +51 more
Jul 19, 2022

NSCLC Trial in Worldwide (Selpercatinib, Carboplatin, Cisplatin)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • Berazategui, Buenos Aires, Argentina
  • +195 more
Jan 30, 2023

Hematopoietic and Lymphoid Cell Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +37 more
  • Birmingham, Alabama
  • +171 more
Aug 24, 2022

Eyelid Dermatochalasis, Dermatochalasis Trial in Miami (Restorative Eye Treatment (RET) cream, INhance with Trihex Technology)

Active, not recruiting
  • Eyelid Dermatochalasis
  • Dermatochalasis
  • Restorative Eye Treatment (RET) cream
  • INhance with Trihex Technology
  • Miami, Florida
    Bascom Palmer Eye Institute, University of Miami
May 16, 2022

Nonsmall Cell Lung Cancer Trial in Shanghai (HS-10365 capsules)

Recruiting
  • Nonsmall Cell Lung Cancer
  • HS-10365 capsules
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Nov 22, 2023

Duchenne Muscular Dystrophy, Becker Muscular Dystrophy Trial in United Kingdom, United States (Ataluren, Chronic Corticosteroid

Terminated
Has Results
  • Duchenne Muscular Dystrophy
  • Becker Muscular Dystrophy
  • Davis, California
  • +5 more
Jul 27, 2020